Evidence map›Paper›PMID 32321846›Full record

ArticleTobacco control2020

Overview of tobacco use transitions for population health.

Andrew Hyland, Karin A Kasza, Nicolette Borek, Heather L Kimmel, Kristie A Taylor, Wilson M Compton, Hannah Day, Elisabeth A Donaldson, Eva Sharma, Gabriella Anic and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tobacco control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Andrew HylandDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA andrew.hyland@roswellpark.org.
Karin A KaszaDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-4492-098X
Nicolette BorekOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Heather L KimmelNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-8278-0095
Kristie A TaylorBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.ORCID 0000-0001-6668-7923
Wilson M ComptonNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Hannah DayOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Elisabeth A DonaldsonOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Eva SharmaBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.ORCID 0000-0002-1328-508X
Gabriella AnicOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Kathryn C EdwardsBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.ORCID 0000-0002-0645-1705
Michael J HalenarBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.ORCID 0000-0002-8703-3811
Lynn C HullOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Wendy KissinBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
Jean LimpertOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Elizabeth L SeamanBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-7944-3570
Lisa D GardnerOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.ORCID 0000-0003-3340-2818
Hoda T HammadOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Cassandra A StantonBehavioral Health and Health Policy Practice, Westat, Rockville, MD, USA.ORCID 0000-0001-5329-6261

Funding

NIDA NIH HHS HHSN271201100027C
6 · The paper itself

Abstract

The Family Smoking Prevention and Tobacco Control Act provided the US Food and Drug Administration authority to regulate tobacco products using a population health standard. Models have been developed to estimate the population health impacts of tobacco initiation, cessation and relapse transitions. Models should be informed by high-quality, longitudinal data to estimate these constructs. Simulation studies have generated data to predict the impact of various tobacco control interventions, including the influence of regulations on tobacco use behaviours and health. The purpose of this paper is to provide a high-level conceptual overview for understanding tobacco transition behaviours and correlates of these behaviours using data from the Population Assessment of Tobacco and Health (PATH) Study, a US nationally representative longitudinal tobacco study of about 46 000 persons aged 12+ years. The papers that follow in this journal issue build and expand on this conceptual overview using data from the first three waves of the PATH Study. These papers describe use patterns of different tobacco products and their correlates, and can serve as foundations for more in-depth papers that will help the research community better understand the population health impacts and drivers of different tobacco use patterns.

Indexed as

Tobacco ProductsAdolescentAdultChildFemaleHumansLongitudinal StudiesMaleMiddle AgedModels, TheoreticalPopulation HealthResearch DesignSmoking CessationSmoking PreventionTobacco UseUnited Stateselectronic nicotine delivery devicesnon-cigarette tobacco productssurveillance and monitoring

Identifiers

PMID32321846
PMCPMC7528885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.